This area of the website is currently undergoing scheduled maintenance and will be back online soon. Please try again later.
PP-XOF-IE-0140-1 | February 2026
▼ This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. Healthcare professional are asked to report any suspected adverse reactions.
